Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypervolemia and Treatment Guided by Bioimpedance in End Stage Renal Disease Patients in Zonguldak (Prospective Study)

NCT01468363 is registered in ClinicalTrials.gov with Zonguldak Bulent Ecevit University as lead sponsor.

NCT NCT01468363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01468363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypervolemia and Treatment Guided by Bioimpedance in End Stage Renal Disease Patients in Zonguldak (Prospective Study)
Lead sponsor
Zonguldak Bulent Ecevit University
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2011
Completion date
November 30, 2012
Enrollment
550 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis fluid allergy